TDOC Teladoc Health Inc.

Teladoc Health Adds GLP-1 Self-Pay Option to Comprehensive Weight Care

Teladoc Health Adds GLP-1 Self-Pay Option to Comprehensive Weight Care

Pharmacy Integration with Gifthealth to Extend Seamless Support for FDA-Approved Medication to Obesity Program Members Without GLP-1 Coverage

PURCHASE, NY, March 06, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC) today announced a pharmacy integration agreement with Eli Lilly’s LillyDirect pharmacy partner, Gifthealth, which will help streamline access to FDA-approved Zepbound® (tirzepatide) for Teladoc Health members enrolled in its Comprehensive Weight Care Program. This option will help members without insurance coverage for GLP-1s for obesity have more seamless access to affordable, safe, and effective medicine.

LillyDirect is Eli Lilly and Company’s direct-to-consumer digital healthcare platform. Eligible Teladoc Health members, if prescribed Zepbound® by their Teladoc Health provider for an on-label indication, can have single-use Zepbound® vials delivered directly to their home. Teladoc Health’s Comprehensive Weight Care and Primary360 teams will have full visibility into each stage of the patient’s Zepbound® fulfillment journey—from dispensing to shipping to delivery to refills.

“At Teladoc Health, we are dedicated to expanding access to clinically responsible, evidence-based care,” said Kelly Bliss, President, U.S. Group Health at Teladoc Health. “We provide the integrated support necessary for patient safety and sustainable health outcomes. By integrating with LillyDirect, we are reducing barriers to high-quality care and helping our members afford transformative FDA-approved treatments while avoiding the potential risks of compounded medications recently offered by others.”

In addition to clinically appropriate medication access, members enrolled in the Teladoc Health Comprehensive Weight Care Program have multi-disciplinary, evidence-based care and support from licensed clinicians who have additional training in obesity medicine, registered dietitians, and expert health coaches. Members receive a connected digital scale, personalized lifestyle coaching, nutrition counseling, mental health support, and proven behavior change resources to help people manage and maintain a healthy weight. Teladoc Health’s end-to-end programs drive high levels of health engagement and meaningful, sustained outcomes for members taking GLP-1 medications.

“At Gifthealth, we are excited to integrate with Teladoc Health to streamline access to Zepbound® for patients in need. Through Gifthealth’s relationship with LillyDirect, we provide a seamless, affordable path for patients to receive this FDA-approved treatment. Our technology-powered solutions aim to remove barriers, improve medication access, and ensure that patients have reliable access to safe and effective weight management treatments,” said Robert Hoppe, EVP of Life Sciences at Gifthealth.  

Pricing information is available at .

About Teladoc Health

Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit .

Media: 

Lou Serio



EN
06/03/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Teladoc Health Inc.

 PRESS RELEASE

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303...

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective March 1, 2026, in connection with commencing employment as Chief Growth Officer, U.S. Group Health, Daniel Conroy was granted an award of restricted stock units covering 57,034 shares of Teladoc Health’s common stock, par value $0.001 per share (“Common Stock”), and an award of performance stock units covering a target of 5...

 PRESS RELEASE

Teladoc Health to Participate in Upcoming Investor Conference

Teladoc Health to Participate in Upcoming Investor Conference NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, will participate in the Barclays 28th Annual Global Healthcare Conference in Miami on March 10th, 2026, at 1:00 p.m. ET. A live audio webcast and replay of the presentation will be available at .  About Teladoc Health Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care pr...

 PRESS RELEASE

Teladoc Health Reports Fourth Quarter and Full Year 2025 Results

Teladoc Health Reports Fourth Quarter and Full Year 2025 Results NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended December 31, 2025 (“Fourth Quarter 2025”) and full year ended December 31, 2025 (“Full Year 2025”). Unless otherwise noted, percentage and other changes are relative to the three months ended December 31, 2024 (“Fourth Quarter 2024”) and full year ended December 31, 2024 (“Full Year 2024”). Highlights Fourth Quarter 2025 revenue of $642.3 million, flat...

 PRESS RELEASE

Teladoc Health Appoints Michael Smith, Experienced Insurance and Finan...

Teladoc Health Appoints Michael Smith, Experienced Insurance and Financial Services Executive, to Its Board of Directors NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Michael Smith to its board of directors. With more than three decades of leadership experience in financial management and strategic transformation, Mr. Smith brings a deep understanding of long-term business sustainability within highly regulated, global markets. He joins the board following the previously announced retirements ...

 PRESS RELEASE

Teladoc Health to Announce Fourth Quarter 2025 Financial Results

Teladoc Health to Announce Fourth Quarter 2025 Financial Results NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release fourth quarter 2025 results on Wednesday, February 25, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day. Conference Call Details The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 330912. For international participants, please visit the...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch